Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sana Biotechnology Inc (NQ: SANA )

8.410 +0.230 (+2.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,330,841
Open 8.280
Bid (Size) 7.900 (1)
Ask (Size) 8.780 (2)
Prev. Close 8.180
Today's Range 8.220 - 8.660
52wk Range 3.925 - 26.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Stocks Due for a Stunning Short Squeeze
If you can handle the heat, these ideas could potentially cook up some massive profits. 
Via InvestorPlace
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga

Performance

YTD
-46.02%
-46.02%
1 Month
+12.73%
+12.73%
3 Month
+71.63%
+71.63%
6 Month
+24.22%
+24.22%
1 Year
-58.71%
-58.71%

More News

Read More
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
DocuSign CEO Shuffle: Why One Analyst Remains On The Sidelines For Now
Via Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Via Benzinga
89 Biggest Movers From Friday
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Sana Biotechnology Inks Two Licensing Pacts For Targets Against Hematological Malignancies
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks Hitting New 52-Week Lows Today
Via Benzinga
Sana Obtains License To Beam Therapeutics' CRISPR Cas12b Gene Editing Technology
Via Benzinga
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
Via Benzinga
Sana Biotech To Establish Manufacturing Facility For Gene, Cell Therapy Candidates
Via Benzinga
70 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Via Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Via Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.